Literature DB >> 6466540

Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas.

K Funa, B Nilsson, G Jacobsson, G V Alm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6466540      PMCID： PMC1976881          DOI： 10.1038/bjc.1984.168

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  Interferons and the immune system.

Authors:  B R Bloom
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

Review 2.  Immunoregulation and natural killer cells.

Authors:  R B Herberman
Journal:  Mol Immunol       Date:  1982-10       Impact factor: 4.407

3.  Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins.

Authors:  H S Koren; S J Anderson; D G Fischer; C S Copeland; P J Jensen
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

4.  A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells.

Authors:  M J Droller; M U Schneider; P Perlmann
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

5.  Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.

Authors:  H F Pross; M G Baines
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

6.  Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.

Authors:  K Funa; G V Alm; L Rönnblom; K Oberg
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.

Authors:  E H Steinhauer; A T Doyle; J Reed; A S Kadish
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

8.  Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.

Authors:  M Takasugi; A Ramseyer; J Takasugi
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

9.  Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease.

Authors:  A S Kadish; A T Doyle; E H Steinhauer; N A Ghossein
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422
  9 in total
  14 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

2.  Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients.

Authors:  M N Satam; J N Suraiya; J J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children.

Authors:  M Bondestam; K Funa; P Venge; G V Alm
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

Review 4.  Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes.

Authors:  Alessandro Di Federico; Mirta Mosca; Rachele Pagani; Riccardo Carloni; Giorgio Frega; Andrea De Giglio; Alessandro Rizzo; Dalia Ricci; Simona Tavolari; Mariacristina Di Marco; Andrea Palloni; Giovanni Brandi
Journal:  Cancers (Basel)       Date:  2022-05-14       Impact factor: 6.575

Review 5.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.

Authors:  Christine V Ichim
Journal:  J Transl Med       Date:  2005-02-08       Impact factor: 5.531

7.  Correlation Between Natural Killer Cell Activity and Systemic Inflammatory Markers for Heterogeneous Cancer Patients Treated With Wheel Balance Cancer Therapy.

Authors:  Hwi-Joong Kang; Kyeore Bae; Jee-Hye Kim; Chong-Kwan Cho; Hwa-Seung Yoo
Journal:  Integr Cancer Ther       Date:  2017-07-17       Impact factor: 3.279

8.  Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer.

Authors:  Eunsung Jun; Ah Young Song; Ji-Wan Choi; Hyeon Ho Lee; Mi-Yeon Kim; Dae-Hyun Ko; Hyo Jeong Kang; Seong Who Kim; Yenan Bryceson; Song Cheol Kim; Hun Sik Kim
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

9.  Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer.

Authors:  Jongmi Lee; Ki Hyun Park; Ji Hyeong Ryu; Hyun Jin Bae; Aeran Choi; Hyeyoung Lee; Jihyang Lim; Kyungja Han; Cho Hyun Park; Eun Sun Jung; Eun-Jee Oh
Journal:  Oncotarget       Date:  2017-07-31

Review 10.  Role of immune cells in pancreatic cancer from bench to clinical application: An updated review.

Authors:  Jae Hyuck Chang; Yongjian Jiang; Venu G Pillarisetty
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.